Mucopolysaccharidoses

Mucopolysaccharidoses (MPS) are a group of inherited genetic disorders characterized by the accumulation of excessive amounts of certain carbohydrate molecules called glycosaminoglycans (GAGs) in cells and tissues. These GAGs can cause damage to the organs and tissues, leading to a wide range of physical and mental impairments. MPS can cause a wide range of medical symptoms, including skeletal abnormalities, hearing loss, cardiac and respiratory problems, and intellectual disabilities. They often affect the nervous system, eyes, and other organs as well. Treatment for MPS is focused on managing symptoms and preventing further progression of the disease. This can include enzyme replacement therapy, physical therapy, dietary modifications, and medications. Early intervention and supportive care are important for individuals living with MPS.

← Journal of Enzymes

Related Articles

1 journal(s) found

Enzymes

ISSN: 2690-4829
Type: Open Access Journal
Editor-in-Chief: Phillip Brumm, C5-6 Technologies LLC.
Journal of Enzyme is an international open access, peer reviewed journal that aims to publish contirbutions in the form of original Research, Review, Literature review, Conference proceedings, Case reports, Short communication, Thesis, Letter to editor and Editorials in the areas of enzyme technology. JEN acts as a forum for the discussion of new